BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 34889689)

  • 21. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
    Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q
    Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
    Yan T; Ye XX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.
    Yang C; Mou Z; Wu S; Ou Y; Zhang Z; Chen X; Dai X; Xu C; Mao S; Jiang H
    Cell Death Dis; 2021 Jul; 12(8):719. PubMed ID: 34285193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA hsa_circ_0000317 inhibits non-small cell lung cancer progression through regulating microRNA-494-3p/phosphatase and tensin homolog deleted on chromosome 10 axis.
    Xia S; Zhang Z
    Clinics (Sao Paulo); 2022; 77():100086. PubMed ID: 35917658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hsa_circ_0023409 Accelerates Gastric Cancer Cell Growth and Metastasis Through Regulating the IRS4/PI3K/AKT Pathway.
    Li J; Yang Y; Xu D; Cao L
    Cell Transplant; 2021; 30():963689720975390. PubMed ID: 33439739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines.
    Chen T; Shao S; Li W; Liu Y; Cao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3638-3648. PubMed ID: 31456425
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of low molecular weight-polycyclic aromatic hydrocarbons responsive hsa_circ_0039929/hsa-miR-15b-3p_R-1/FGF2 circuit on inflammatory response of A549 cells via the PI3K/AKT pathway and epithelial-mesenchymal transition process.
    Huang Y; Huang Y; Wang H; Zhang H; Shi L; Li C; Li X; Zeng Y; Liu Y; Wu M; Wang J; Wang J
    Environ Toxicol; 2022 Aug; 37(8):2005-2018. PubMed ID: 35475590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circ_0000423 promotes gastric cancer cell proliferation, migration and invasion via the microR-582-3p/Disheveled-Axin domain containing 1 axis.
    Huang CQ; Yang P; Liu J; Wang YP; Hao DD; Yang X
    Bioengineered; 2021 Dec; 12(2):12755-12766. PubMed ID: 34898351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of circ_0000142 promotes multiple myeloma progression by adsorbing miR-610 and upregulating AKT3 expression.
    Liu F; Wang YL; Wei JM; Huang ZD
    J Biochem; 2021 Apr; 169(3):327-336. PubMed ID: 32970816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Puerarin Inhibits the Progression of Bladder Cancer by Regulating circ_0020394/miR-328-3p/NRBP1 Axis.
    Du L; Zhang L; Sun F
    Cancer Biother Radiopharm; 2022 Aug; 37(6):435-450. PubMed ID: 33016781
    [No Abstract]   [Full Text] [Related]  

  • 31. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
    Xu S; Ge J; Zhang Z; Zhou W
    Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0000376 downregulation inhibits the progression of non-small cell lung cancer by mediating the miR-488-3p/BRD4 axis and the PI3K/PKB signaling pathway.
    Yuan H; Wu H; Cheng J; Xiong J
    Histol Histopathol; 2021 Dec; 36(12):1309-1324. PubMed ID: 34730838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p.
    Chen X; Tang Y; Yan J; Li L; Jiang L; Chen Y
    J Dermatol Sci; 2021 Sep; 103(3):176-182. PubMed ID: 34454812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
    Qi Q; Sun Y; Yang Y; Liu Y
    Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
    Fan L; Cao X; Lei Y
    Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircLRRK1 targets miR-223-3p to inhibit the proliferation, migration and invasion of trophoblast cells by regulating the PI3K/AKT signaling pathway.
    Tang R; Zhang Z; Han W
    Placenta; 2021 Jan; 104():110-118. PubMed ID: 33310596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway.
    Liu D; Ma X
    Int J Med Sci; 2021; 18(14):3224-3235. PubMed ID: 34400892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.